These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3350045)

  • 1. The influence of oxaprotiline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens.
    Maj J; Wedzony K
    Eur J Pharmacol; 1988 Jan; 145(2):97-103. PubMed ID: 3350045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of (+)- and (-)-oxaprotiline administered repeatedly on the dopamine system.
    Maj J; Klimek V; Rogóz Z; Skuza G; Sowińska H
    J Neural Transm Gen Sect; 1991; 86(1):11-23. PubMed ID: 1751026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists.
    Maj J; Papp M; Skuza G; Bigajska K; Zazula M
    J Neural Transm; 1989; 76(1):29-38. PubMed ID: 2565359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desipramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected into the nucleus accumbens.
    Maj J; Wedzony K; Klimek V
    Eur J Pharmacol; 1987 Aug; 140(2):179-85. PubMed ID: 2889605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single treatments with the antidepressant oxaprotiline and its (+) and (-) enantiomers increase behavioural responses to dopaminergic stimulation in the rat.
    Delini-Stula A; Mogilnicka E
    J Neural Transm; 1988; 71(2):91-8. PubMed ID: 3346651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaprotiline enantiomers given repeatedly and brain alpha-adrenoceptors.
    Maj J; Wedzony K; Klimek V; Rogóz Z; Skuz G
    J Neural Transm Gen Sect; 1990; 80(3):213-23. PubMed ID: 2158798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory behaviour, exploration and locomotion following NMDA or 6-OHDA lesions in the rat nucleus accumbens.
    Weissenborn R; Winn P
    Behav Brain Res; 1992 Nov; 51(2):127-37. PubMed ID: 1466779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
    Joyce EM; Koob GF
    Psychopharmacology (Berl); 1981; 73(4):311-3. PubMed ID: 6789349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some central pharmacological effects of (+)- and (-)-oxaprotiline.
    Maj J; Rogóź Z; Skuza G; Sowińska H
    J Neural Transm Gen Sect; 1990; 80(2):129-43. PubMed ID: 2317315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced dopamine receptor activation in accumbens and frontal cortex has opposite effects on medial forebrain bundle self-stimulation.
    Olds ME
    Neuroscience; 1990; 35(2):313-25. PubMed ID: 2199840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens.
    Kolta MG; Shreve P; Uretsky NJ
    Neuropharmacology; 1989 Jan; 28(1):9-14. PubMed ID: 2927583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-like effects of (+)-oxaprotiline on a behavioral screen.
    Marek GJ; Li A; Seiden LS
    Eur J Pharmacol; 1988 Nov; 157(2-3):183-8. PubMed ID: 3224637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the mesencephalic locomotor region with locomotor activity induced by injections of amphetamine into the nucleus accumbens.
    Brudzyński SM; Mogenson GJ
    Brain Res; 1985 May; 334(1):77-84. PubMed ID: 2986781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat.
    Kafetzopoulos E
    Psychopharmacology (Berl); 1986; 88(3):271-4. PubMed ID: 3083447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine-dependent hyperactivity in the rat following manipulation of GABA mechanisms in the region of the nucleus accumbens.
    Pycock CJ; Horton RW
    J Neural Transm; 1979; 45(1):17-33. PubMed ID: 112217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P; Robbins TW
    Neuropharmacology; 1985 Jan; 24(1):25-31. PubMed ID: 3920545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (+)-Oxaprotiline but not (-)-oxaprotiline given chronically potentiates the aggressive behaviour induced by clonidine.
    Maj J; Rogóz Z; Skuza G
    J Pharm Pharmacol; 1983 Mar; 35(3):180-1. PubMed ID: 6132979
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of repeated treatment with oxaprotiline enantiomers on central 5-HT receptor subpopulations.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(2):133-50. PubMed ID: 8401766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ; Rankin J
    Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.